A new report published today (Tuesday 10th June 2014) by Cancer52 shows that the percentage of cancer deaths from those cancers outside...

On 5th June 2014, Cancer52 published its Briefing Paper on Access to Orphan Medicines in the UK.

Cancer52 is delighted to announce that Clara Mackay, Deputy CEO of Pancreatic Cancer UK, has been appointed as interim chair of Cancer52....

On the basis of the increasing experience of our members with NICE Technology Appraisals Cancer52 has commented in detail on a number of...

On the basis of the increasing experience of our members with NICE Technology Appraisals Cancer52 has commented in detail on a number of...

On 24th February 2014, Cancer52 published its Briefing Paper on the UK Strategy for Rare Diseases.

Making sure that rare cancers aren’t written out of the script Cancer52 published its briefing paper on the UK Strategy for Rare...

On 21st February 2014, Cancer52 published its Briefing Paper "VBA: NICE do it their way".

Cancer52 published its briefing paper "NICE and Value Based Assessment (VBA) - NICE do it their way." NICE is due to consult on its...

The National Cancer Research Institute (NCRI) and Cancer52 have published a report "Research into less common cancers". It shows for the...